Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paloma Morales de los Ríos Luna"'
Autor:
Paulina Maravilla-Herrera, María Merino, Santiago Alfonso Zamora, Jesús Balea Filgueiras, José Manuel Carrascosa Carrillo, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio García-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de los Ríos Luna, Lluís Puig, Sandra Ros, Álvaro Hidalgo-Vega
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionPsoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e., response) are assessed through the Psoriasis Area and Severity Index (PASI). A PASI 75 resp
Externí odkaz:
https://doaj.org/article/0425efa1f7f34b929bd2f6ccd7239b0c
Autor:
Néboa Zozaya, Renata Villoro, Fernando Abdalla, Santiago Alfonso Zamora, Jesús Balea Filgueiras, José Manuel Carrascosa Carrillo, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio García-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de los Ríos Luna, Lluis Puig Sanz, Sandra Ros, Álvaro Hildago-Vega
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients’ quality of life. The aim of this study was to identify and determine the relative importance of unmet needs in the management of moderate-t
Externí odkaz:
https://doaj.org/article/108c603241314e2a80f94818fdd7dfc8
Autor:
Estela García-Martín, RM Romero-Jiménez, Ofelia Baniandrés-Rodríguez, Vicente Escudero-Vilaplana, Juana Benedí-González, Paloma Morales de los Ríos Luna, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
European Journal of Hospital Pharmacy. :ejhpharm-2022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35bb671c40480cfa987532a705b26440
https://doi.org/10.1136/ejhpharm-2022-003594
https://doi.org/10.1136/ejhpharm-2022-003594
Autor:
Néboa Zozaya, Fernando Abdalla, Santiago Alfonso Zamora, Jesús Balea Filgueiras, José Manuel Carrascosa Carrillo, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio García-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de Los Ríos Luna, Lluis Puig, Sandra Ros, Álvaro HIdalgo-Vega
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(6)
Multi-criteria decision analysis (MCDA) was proposed to surmount arbitrary clinical decisions in the field of biological therapies for psoriatic patients. At the same time, MCDA may further highlight the potential of bimekizumab for the treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319b0de0272574034a05138e462d0262
https://pubmed.ncbi.nlm.nih.gov/35404728
https://pubmed.ncbi.nlm.nih.gov/35404728